61.31
price up icon1.53%   0.88
 
loading
Schlusskurs vom Vortag:
$60.43
Offen:
$61.09
24-Stunden-Volumen:
7.53M
Relative Volume:
1.35
Marktkapitalisierung:
$24.05B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$571.50M
KGV:
42.92
EPS:
1.4285
Netto-Cashflow:
$570.80M
1W Leistung:
-11.38%
1M Leistung:
-8.49%
6M Leistung:
-24.83%
1J Leistung:
-11.97%
1-Tages-Spanne:
Value
$58.88
$62.39
1-Wochen-Bereich:
Value
$56.45
$69.17
52-Wochen-Spanne:
Value
$56.45
$93.25

Dexcom Inc Stock (DXCM) Company Profile

Name
Firmenname
Dexcom Inc
Name
Telefon
(858) 200-0200
Name
Adresse
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Mitarbeiter
10,300
Name
Twitter
@dexcom
Name
Nächster Verdiensttermin
2024-10-24
Name
Neueste SEC-Einreichungen
Name
DXCM's Discussions on Twitter

Vergleichen Sie DXCM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
DXCM
Dexcom Inc
61.34 23.57B 4.30B 571.50M 570.80M 1.4285
Medical Devices icon
ABT
Abbott Laboratories
125.30 215.34B 43.84B 13.90B 6.92B 7.9725
Medical Devices icon
BSX
Boston Scientific Corp
98.42 146.15B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
361.67 136.97B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
90.05 115.69B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
84.08 48.77B 5.88B 1.34B 577.90M 2.3455

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-21 Fortgesetzt Stifel Buy
2025-09-08 Herabstufung Oppenheimer Outperform → Perform
2025-08-21 Eingeleitet Argus Buy
2025-06-16 Eingeleitet Truist Buy
2025-05-30 Eingeleitet Goldman Buy
2025-04-10 Eingeleitet Mizuho Outperform
2025-02-03 Hochstufung Redburn Atlantic Neutral → Buy
2025-01-16 Hochstufung Robert W. Baird Neutral → Outperform
2024-07-26 Herabstufung JP Morgan Overweight → Neutral
2024-07-26 Herabstufung Robert W. Baird Outperform → Neutral
2024-05-30 Eingeleitet Redburn Atlantic Neutral
2024-03-12 Eingeleitet RBC Capital Mkts Outperform
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-04-17 Hochstufung Raymond James Outperform → Strong Buy
2023-03-29 Eingeleitet UBS Buy
2023-01-26 Eingeleitet Wolfe Research Outperform
2022-10-18 Eingeleitet Barclays Equal Weight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-15 Eingeleitet Bernstein Outperform
2022-03-02 Fortgesetzt BofA Securities Buy
2022-02-03 Hochstufung BTIG Research Neutral → Buy
2022-01-19 Hochstufung Wells Fargo Equal Weight → Overweight
2022-01-07 Hochstufung Guggenheim Neutral → Buy
2021-10-18 Herabstufung Guggenheim Buy → Neutral
2021-07-21 Fortgesetzt Cowen Outperform
2021-05-28 Hochstufung Wells Fargo Underweight → Equal Weight
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Overweight
2021-01-06 Hochstufung UBS Neutral → Buy
2020-10-02 Herabstufung Wells Fargo Equal Weight → Underweight
2020-05-27 Bestätigt Piper Sandler Overweight
2020-05-14 Eingeleitet Wells Fargo Equal Weight
2020-03-05 Eingeleitet Citigroup Buy
2019-11-07 Bestätigt Canaccord Genuity Buy
2019-11-07 Hochstufung Guggenheim Neutral → Buy
2019-10-23 Eingeleitet Stifel Buy
2018-11-28 Eingeleitet UBS Neutral
2018-10-19 Hochstufung Goldman Sell → Neutral
2018-09-12 Hochstufung Northland Capital Under Perform → Market Perform
2018-08-02 Bestätigt Canaccord Genuity Buy
2018-07-02 Hochstufung Raymond James Mkt Perform → Outperform
2018-06-08 Hochstufung JP Morgan Neutral → Overweight
2018-05-11 Eingeleitet BofA/Merrill Buy
2018-05-03 Bestätigt Canaccord Genuity Buy
2018-04-04 Eingeleitet Goldman Sell
2018-04-04 Eingeleitet Guggenheim Neutral
2018-03-23 Hochstufung Robert W. Baird Neutral → Outperform
2018-01-04 Herabstufung Northland Capital Market Perform → Under Perform
2017-09-28 Bestätigt Wedbush Outperform
Alle ansehen

Dexcom Inc Aktie (DXCM) Neueste Nachrichten

pulisher
12:00 PM

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

12:00 PM
pulisher
11:45 AM

ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important ... - Bluefield Daily Telegraph

11:45 AM
pulisher
11:42 AM

ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. - GlobeNewswire

11:42 AM
pulisher
11:05 AM

Dexcom recalls G6 CGM app over software problem - MedTech Dive

11:05 AM
pulisher
10:32 AM

DexCom (NASDAQ:DXCM) Given "Buy" Rating at Truist Financial - MarketBeat

10:32 AM
pulisher
10:25 AM

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

10:25 AM
pulisher
08:15 AM

Is DexCom Inc. (DC4) stock cheap by valuation metricsMarket Risk Summary & Community Consensus Picks - newser.com

08:15 AM
pulisher
08:13 AM

Can DexCom Inc. (DC4) stock hit consensus price targetsPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com

08:13 AM
pulisher
08:00 AM

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar

08:00 AM
pulisher
06:03 AM

Freestone Capital Holdings LLC Purchases 7,242 Shares of DexCom, Inc. $DXCM - MarketBeat

06:03 AM
pulisher
04:49 AM

What MACD and RSI say about DexCom Inc.CEO Change & Smart Money Movement Alerts - newser.com

04:49 AM
pulisher
03:55 AM

Has DexCom Inc. found a price floor2025 Big Picture & Real-Time Volume Surge Alerts - newser.com

03:55 AM
pulisher
03:52 AM

Will breakout in DexCom Inc. lead to full recoveryQuarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com

03:52 AM
pulisher
03:34 AM

Will DexCom Inc. stock continue dividend increasesDollar Strength & Verified Chart Pattern Trade Signals - newser.com

03:34 AM
pulisher
03:10 AM

Building trade automation scripts for DexCom Inc.July 2025 Breakouts & Weekly Setup with High ROI Potential - newser.com

03:10 AM
pulisher
02:31 AM

DexCom, Inc. Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo

02:31 AM
pulisher
01:56 AM

DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

01:56 AM
pulisher
Nov 03, 2025

Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)Levi & Korsinsky Represents Shareholders - ACCESS Newswire

Nov 03, 2025
pulisher
Nov 03, 2025

Lost Money on DexCom, Inc. (DXCM)? Urged to Join Class Action Before December 26, 2025Contact Levi & Korsinsky - ACCESS Newswire

Nov 03, 2025
pulisher
Nov 03, 2025

Stockholder Alert: Robbins LLP Informs Investors of the Dexcom, Inc. Class Action Lawsuit - PR Newswire

Nov 03, 2025
pulisher
Nov 03, 2025

DexCom (DXCM): UBS Lowers Price Target to $95, Maintains 'Buy' R - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

DexCom Faces Class Action Over Alleged Investor Deception - TipRanks

Nov 03, 2025
pulisher
Nov 03, 2025

DXCM CLASS ACTION LAWSUIT: A Securities Fraud Class Action - GlobeNewswire

Nov 03, 2025
pulisher
Nov 03, 2025

DexCom Stock Rises 3.7% on November 3, 2025 | DXCM NewsNews and Statistics - IndexBox

Nov 03, 2025
pulisher
Nov 03, 2025

DexCom (DXCM) Stock Is Up, What You Need To Know - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

DexCom Growth Outlook Likely Sustainable, UBS Says - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

UBS Adjusts DexCom Price Target to $95 From $106, Maintains Buy Rating - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Truist Securities Reiterates Buy Rating on DexCom (DXCM) Despite - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Nov 03, 2025
pulisher
Nov 03, 2025

Is DexCom Inc. (DC4) stock a top pick for value investorsPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can DexCom Inc. stock maintain operating marginsInsider Selling & Stock Portfolio Risk Management - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will DexCom Inc. stock maintain momentum in 2025Inflation Watch & Weekly Momentum Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What does recent volatility data suggest for DexCom Inc.2025 Big Picture & Verified Entry Point Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is DexCom Inc. stock reversal real or fakeQuarterly Investment Review & Daily Stock Trend Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

FY2025 EPS Estimates for DexCom Increased by Leerink Partnrs - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

What is William Blair's Forecast for DexCom FY2025 Earnings? - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Is DexCom Inc. stock attractive for passive investors2025 Momentum Check & Safe Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

DexCom Inc. stock chart pattern explainedMarket Performance Summary & Consistent Profit Focused Trading Strategies - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is DexCom Inc. (DC4) stock a buy for dividend portfoliosWall Street Watch & Daily Oversold Bounce Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can DexCom Inc. stock sustain free cash flow growthEarnings Trend Report & Advanced Swing Trade Entry Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will a bounce in DexCom Inc. offer an exitInflation Watch & Breakout Confirmation Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)Contact Kessler Topaz Meltzer & Check, LLP - The Malaysian Reserve

Nov 02, 2025
pulisher
Nov 02, 2025

Earnings Beat: DexCom, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st

Nov 02, 2025
pulisher
Nov 02, 2025

Geneva Capital Management LLC Increases Stock Holdings in DexCom, Inc. $DXCM - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

DexCom, Inc. $DXCM Shares Acquired by Strs Ohio - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

DexCom, Inc. (NASDAQ:DXCM) Q3 2025 Earnings Call Transcript - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Is DexCom Inc. (DC4) stock supported by free cash flowQuarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

DexCom (NASDAQ:DXCM) Price Target Lowered to $75.00 at JPMorgan Chase & Co. - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

What catalysts could drive DexCom Inc. stock higherWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

DexCom Sees Unusually Large Options Volume (NASDAQ:DXCM) - MarketBeat

Nov 01, 2025

Finanzdaten der Dexcom Inc-Aktie (DXCM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$240.49
price up icon 1.27%
$321.12
price up icon 0.72%
medical_devices PHG
$28.07
price up icon 3.15%
$74.78
price up icon 0.48%
medical_devices EW
$84.05
price up icon 1.14%
Kapitalisierung:     |  Volumen (24h):